OSTX · OS Therapies Inc · Documents
$1.26
-0.01 (-0.79%)
At close · Oct 20
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company's ability to continue as a going concern within one year after the date that the unaudited consolidated financial statements are issued.”View the 10-Q filed Aug 14, 2026
Market Cap
$58.58M
Shares
46.13M
Volume · Oct 20
320.66K
Avg daily vol (3M)
581.44K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | OS Therapies completed an initial closing on October 15, 2026 of a warrant inducement to exercise at $1.30 per share, with seven participants exercising warrants for 5,517,253 shares and yielding approximately $7.2 million in gross proceeds. | 2026-10-19 | 2026-10-15 | |
| 8-K | — | 2026-10-05 | 2026-09-29 | |
| 8-K | — | 2026-09-10 | — | |
| 8-K | — | 2026-09-09 | — | |
| 8-K | — | 2026-08-21 | — | |
| 10-Q | — | 2026-08-14 | 2026-06-30 | |
| 8-K | — | 2026-08-12 | 2026-08-06 | |
| 8-K | — | 2026-08-06 | 2026-07-31 | |
| 8-K | — | 2026-07-29 | 2026-07-23 | |
| ARS | — | 2026-07-24 | 2025-12-31 | |
| DEF 14A | — | 2026-07-24 | 2026-09-09 | |
| DEFA14A | — | 2026-07-24 | — | |
| 8-K/A | — | 2026-07-07 | 2026-06-30 | |
| 8-K | — | 2026-07-02 | 2026-06-30 | |
| 10-Q | — | 2026-05-18 | 2026-03-31 | |
| NT 10-Q | — | 2026-05-15 | 2026-03-31 | |
| 8-K | — | 2026-04-30 | — | |
| 8-K | — | 2026-04-02 | 2026-03-31 | |
| 10-K | — | 2026-03-31 | 2025-12-31 | |
| 8-K | — | 2026-03-31 | — | |
| 8-K | — | 2026-03-06 | 2026-03-04 | |
| 8-K | — | 2026-02-13 | 2026-02-10 | |
| 8-K | — | 2026-01-12 | 2026-01-10 | |
| 10-Q | — | 2025-11-14 | 2025-09-30 | |
| 8-K | — | 2025-10-21 | — | |
| DEFA14A | — | 2025-10-17 | — | |
| 8-K | — | 2025-10-17 | 2025-10-14 | |
| 8-K | — | 2025-09-30 | — | |
| 8-K | — | 2025-09-02 | — | |
| ARS | — | 2025-08-26 | 2024-12-31 | |
| 8-K | — | 2025-08-26 | 2025-08-25 | |
| DEFA14A | — | 2025-08-25 | — | |
| DEF 14A | — | 2025-08-25 | 2025-10-14 | |
| 8-K | — | 2025-08-19 | — | |
| 10-Q | — | 2025-08-18 | 2025-06-30 | |
| NT 10-Q | — | 2025-08-15 | 2025-06-30 | |
| 8-K | — | 2025-08-15 | — | |
| PRE 14A | — | 2025-08-15 | — | |
| S-3 | — | 2025-08-08 | — | |
| S-1 | — | 2025-08-04 | — | |
| 8-K | — | 2025-07-14 | 2025-07-11 | |
| 8-K | — | 2025-06-27 | 2025-06-26 | |
| 8-K | — | 2025-06-24 | 2025-06-23 | |
| S-1 | — | 2025-05-23 | — | |
| 8-K | — | 2025-05-16 | — | |
| 10-Q | — | 2025-05-15 | 2025-03-31 | |
| 8-K | — | 2025-04-15 | 2025-04-09 | |
| 8-K | — | 2025-04-09 | — | |
| 8-K | — | 2025-04-02 | 2025-03-31 | |
| DEFA14A | — | 2025-04-02 | — |
Showing 1–50 of 83 filings